The existing authors done an open up-label pilot research that administered psilocybin to 15 remedy-resistant tobacco/nicotine-dependent people who smoke, from the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Members were being administered ~0.29 mg/kg oral psilocybin on the participant’s concentrate on day t